Pfizer Inc. (NEO:PFE)

Market Cap	195.93B
Revenue (ttm)	87.54B
Net Income (ttm)	13.70B
Shares Out	n/a
EPS (ttm)	2.41
PE Ratio	14.30
Forward PE	8.56
Dividend	0.78 (6.88%)
Ex-Dividend Date	Nov 7, 2025

Volume	66,503
Average Volume	94,274
Open	11.56
Previous Close	11.58
Day's Range	11.35 - 11.56
52-Week Range	9.68 - 12.76
Beta	0.42
RSI	44.93
Earnings Date	Feb 3, 2026

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1849
• Employees: 81,000
• Stock Exchange: Cboe Canada
• Ticker Symbol: PFE

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD